AB
CGON icon

Amalgamated Bank’s CG Oncology CGON Stock Holding History

Amalgamated Bank’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,756
Closed -$73K – 1854
2025
Q4 		$73K Sell
1,756
-109
-6% -$4.51K ﹤0.01% 1747
2025
Q3 		$75K Hold
1,865
– – ﹤0.01% 1744
2025
Q2 		$48K Hold
1,865
– – ﹤0.01% 1836
2025
Q1 		$46K Buy
1,865
+244
+15% +$6.86K ﹤0.01% 1807
2024
Q4 		$46K Hold
1,621
– – ﹤0.01% 1851
2024
Q3 		$61K Buy
1,621
+840
+108% +$29.4K ﹤0.01% 1791
2024
Q2 		$25K Hold
781
– – ﹤0.01% 2041
2024
Q1 		$34K Buy
+781
New +$31.9K ﹤0.01% 1962

Other funds holding CGON

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Amalgamated Bank's CGON Position: Q1 2026 in Review

Amalgamated Bank sold out of CG Oncology (CGON) in Q1 2026, closing a stake of 1,756 shares — an estimated $73K sold.

Amalgamated Bank first reported a position in CGON in Q1 2024 and held it in 8 quarters. The position peaked at $75K in Q3 2025. 233 funds tracked by Wall St. Rank hold CGON as of Q1 2026.

  • Amalgamated Bank reported no remaining CG Oncology position as of Q1 2026 after selling out during the quarter.
  • Amalgamated Bank sold 1,756 CG Oncology shares in Q1 2026, an estimated $73K.
  • Amalgamated Bank first reported a position in CG Oncology in Q1 2024 and held it in 8 quarters.
  • Amalgamated Bank's CG Oncology position peaked at $75K in Q3 2025.
  • 233 funds tracked by Wall St. Rank held CG Oncology as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.